Posted by Michael Wonder on 08 Jan 2024
US Food and Drug Administration approves Zelsumvi as a first in class medication for the treatment of molluscum contagiosum
5 January 2023 - Zelsumvi is expected to be commercially available during the second half of 2024.
Ligand Pharmaceuticals today announced that the US FDA has approved Zelsumvi (berdazimer 10.3% topical gel) for the treatment of molluscum contagiosum (molluscum) in adults and paediatric patients one year of age and older.
